HPV Vaccination Behavior, Vaccine Preference, and Health Beliefs in Chinese Female Health Care Workers: A Nationwide Cross-Sectional Study

Author:

Shao Xiaoping1,Lu Xinyue2,Zhou Weiyu2,Huang Weifeng1,Lu Yihan2ORCID

Affiliation:

1. Department of Intensive Care Medicine, The Sixth People’s Hospital, Shanghai Jiao Tong University, Shanghai 200233, China

2. Department of Epidemiology, Ministry of Education Key Laboratory of Public Health Safety, Fudan University School of Public Health, Shanghai 200032, China

Abstract

Human papillomavirus (HPV) vaccination has been proven to be the most effective method to prevent cervical cancer. This study aimed to determine the HPV vaccination behavior and preference in Chinese female health care workers. A nationwide cross-sectional study was performed to recruit 15,967 respondents aged 18–45 years from 31 provinces in China’s mainland in 2021. Of them, 30.0% have been vaccinated or have made an appointment. Regardless of actual vaccination status, respondents mostly preferred the 9-valent HPV vaccine (58.6%), followed by 4-valent (15.6%) and 2-valent vaccines (3.1%); additionally, 17.9% did not have a preference. Moreover, health beliefs on HPV and HPV vaccination were measured using a health belief model (HBM) analysis. Six HBM constructs differed significantly by HPV vaccination status. Higher levels of perceived susceptibility (beta = 0.074), perceived benefit (beta = 0.072), self-efficacy (beta = 0.304), and cues to action (beta = 0.039) scales were significantly associated with increasing HPV vaccine uptake. In contrast, perceived severity (beta = −0.019) and perceived barriers (beta = −0.089) were negative factors. In conclusion, HPV vaccine uptake is high in Chinese female health care workers. HBM constructs may be effective in facilitating the improvement and delivery of targeted intervention programs to increase HPV vaccine uptake.

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference30 articles.

1. HPV and HPV-associated diseases;Dunne;Infect. Dis. Clin. N. Am.,2013

2. International Agency for Research on Cancer (IARC) (2022, March 30). Estimated Number of Deaths from 2018 to 2040, Cervix Uteri, Females, All Ages. Available online: https://gco.iarc.fr/tomorrow/en/dataviz/isotype.

3. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J. Clin.,2021

4. Global Alliance for Vaccines and Immunization (GAVI) (2022, March 30). Human Papillomavirus Vaccine Support. Available online: https://www.gavi.org/types-support/vaccine-support/human-papillomavirus.

5. World Health Organization (WHO) (2022, March 30). Cervical Cancer Elimination Strategy. Available online: https://www.who.int/director-general/speeches/detail/cervical-cancer-an-ncd-we-can-overcome.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3